These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30663211)

  • 21. Philadelphia Chromosome in an Infant With Pro-B Acute Lymphoblastic Leukemia.
    Das A; Bansal D; Sreedharanunni S; Naseem S
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):79-80. PubMed ID: 27820127
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Nishii K; Sakakura M; Tsukada T; Ryuu H; Katayama N
    Int J Hematol; 2007 Apr; 85(3):273-4. PubMed ID: 17483068
    [No Abstract]   [Full Text] [Related]  

  • 23. Philadelphia chromosome-positive acute lymphoblastic leukemia and Down syndrome.
    Tamaura M; Iwasaki F; Yokosuka T; Fukuda K; Hamonoue S; Goto H
    Pediatr Int; 2016 Aug; 58(8):794-7. PubMed ID: 27325175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.
    Mustafa Ali MK; Sabha MM; Al-Rabi KH
    Platelets; 2015; 26(5):491-4. PubMed ID: 25025538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can we increase the cure rate of adults with acute lymphoblastic leukemia?
    Arlin ZA; Feldman EJ
    Leukemia; 1989 Apr; 3(4):318-20. PubMed ID: 2927182
    [No Abstract]   [Full Text] [Related]  

  • 26. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
    J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation.
    Vigna E; Gentile M; Giagnuolo G; Recchia AG; Bossio S; De Stefano L; Morelli R; Morabito F
    Leuk Lymphoma; 2016 Oct; 57(10):2445-7. PubMed ID: 26879289
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute lymphoblastic leukemia].
    Hatta Y
    Rinsho Ketsueki; 2014 Feb; 55(2):185-90. PubMed ID: 24598186
    [No Abstract]   [Full Text] [Related]  

  • 29. Philadelphia chromosome positive acute lymphocytic leukemia arising from aplastic anemia.
    Takeuchi M; Soda R; Takahashi K; Kimura F; Lai M; Ueda Y
    Am J Hematol; 2000 Mar; 63(3):161-2. PubMed ID: 10679810
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome‑positive acute lymphoblastic leukemia.
    Takashima S; Miyamoto T; Kamimura T; Yoshimoto G; Yoshida S; Henzan H; Takase K; Kato K; Ito Y; Ohno Y; Nagafuji K; Eto T; Techima T; Akashi K
    Int J Hematol; 2015 Dec; 102(6):689-96. PubMed ID: 26475283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and safety of tyrosine kinase inhibitor dasatinib plus chemotherapy in the treatment of childhood Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Guo Y; Liu TF; Yang WY; Wang SC; Ruan M; Chen XJ; Zhang L; Liu F; Zou Y; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):634-7. PubMed ID: 26108329
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Milone JH; Enrico A
    Leuk Lymphoma; 2009 Dec; 50 Suppl 2():9-15. PubMed ID: 20017606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.
    Bohnstedt C; Taskinen M; Zeller B; Björgvinsdóttir H; Hafsteinsdottir S; Schmiegelow K
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):79-80. PubMed ID: 19125098
    [No Abstract]   [Full Text] [Related]  

  • 34. Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lestingi TM; Hooberman AL
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):161-75. PubMed ID: 8449857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.
    Forghieri F; Luppi M; Potenza L
    Hematology; 2015 Dec; 20(10):618-9. PubMed ID: 26574786
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
    Ottmann OG; Pfeifer H
    Hematology Am Soc Hematol Educ Program; 2009; ():371-81. PubMed ID: 20008223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kong Y; Chang YJ; Liu YR; Wang YZ; Jiang Q; Jiang H; Qin YZ; Hu Y; Lai YY; Duan CW; Hong DL; Huang XJ
    Leukemia; 2014 Dec; 28(12):2398-401. PubMed ID: 25135692
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
    Jabbour E; Kantarjian H; Ravandi F; Thomas D; Huang X; Faderl S; Pemmaraju N; Daver N; Garcia-Manero G; Sasaki K; Cortes J; Garris R; Yin CC; Khoury JD; Jorgensen J; Estrov Z; Bohannan Z; Konopleva M; Kadia T; Jain N; DiNardo C; Wierda W; Jeanis V; O'Brien S
    Lancet Oncol; 2015 Nov; 16(15):1547-1555. PubMed ID: 26432046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dasatinib-induced nephrotic syndrome.
    Hirano T; Hashimoto M; Korogi Y; Tsuji T; Miyanaka K; Yamasaki H; Tsuda H
    Leuk Lymphoma; 2016; 57(3):726-7. PubMed ID: 26436329
    [No Abstract]   [Full Text] [Related]  

  • 40. Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance.
    Ariës IM; van den Dungen RE; Koudijs MJ; Cuppen E; Voest E; Molenaar JJ; Caron HN; Pieters R; den Boer ML
    Haematologica; 2015 Apr; 100(4):e132-6. PubMed ID: 25480501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.